Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp Regulatory News (PEYS)

Share Price Information for Partners Grp (PEYS)

Share Price is delayed by 15 minutes
Get Live Data
760.00    1.00 (0.13%)
Bid:
760.00
Ask:
772.00
Spread: 12.00 (1.579%)
Market Cap: £514.59m
PEYS Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp Share Chart

PGPE Ltd publishes December NAV

16 Feb 2026 07:00

RNS Number : 1431T
Partners Group Private Equity Ltd
16 February 2026
 

(LSE: PEY/PEYS)

 

Partners Group Private Equity Limited

 

NAV decreased by 2.8% in December 2025

 

 

· NAV decreased to EUR 13.00 per share as of 31 December 2025, corresponding to EUR 891.52 million. Across the full year 2025, NAV total return was down 8.7%, primarily impacted by currency headwinds (-5.7%)

· Portfolio revaluations (-2.1%) and unfavorable currency movements (-0.6%) impacted NAV in December

· PGPE Ltd received EUR 57.7 million in distributions and invested EUR 13.5 million during the month

· As of 31 December 2025, PGPE Ltd had cash and cash equivalents of EUR 8.1 million and an undrawn credit facility of EUR 150 million

· PGPE Ltd spent EUR 5.8 million on share buybacks in Q4 2025, acquiring 562,025 ordinary shares under the EUR 15 million program announced in October 2025

 

In December 2025, NAV was affected by continued US dollar weakness against the euro as well as revaluations that were largely related to two direct investments. Ammega, a global leader in belting solutions, was confronted with continued industry-wide softer trading performance but still demonstrated operational resilience. Pharmathen, a leading contract development and manufacturing organization specialized in advanced drug delivery, experienced a disruption in its long acting injectables manufacturing operations.

 

Portfolio activity overall remained robust. PGPE Ltd received EUR 57.7 million in December, bringing the full year proceeds to more than EUR 200 million and marking the highest quantum of distributions received since 2021. This is in contrast to continued low levels of distributions across the global private equity industry as a whole.

 

A significant portion of December's proceeds stemmed from International Schools Partnership ("ISP"), following the sale of a 20% stake to CVC Strategic Opportunities. Since its founding in 2013, ISP has evolved into a global K‑12 education platform operating 111 schools across 25 countries. As part of the transaction, PGPE Ltd received proceeds amounting to EUR 42.3 million and also reinvested EUR 13.2 million to retain participation in the company's next phase of growth. Future value creation at ISP will focus on continued expansion, enhanced proprietary technology in teaching, and further investment in school infrastructure.

 

Other distributions included EUR 3.4 million from Esentia Energy Development, a fully integrated natural gas pipeline network in Mexico, which began trading on the Mexican Stock Exchange on 20 November 2025, following the pricing of its initial public offering. Further distributions included EUR 3.7 million in proceeds from the exit of Park Place Technologies, a US-headquartered third-party maintenance provider of 'post-warranty' data center maintenance services, and an additional EUR 4.1 million related to the previously announced sale of Apex Logistics, an integrated global logistics solutions provider.

 

A total of EUR 57.6 million was distributed to shareholders across the full year 2025, predominantly through EUR 51.8 million in dividends, recognizing the importance placed by the Board on regular and predictable distributions to shareholders. This reflects the dividend policy of paying to shareholders annually 5% of the previous year end's closing net assets. The remaining EUR 5.8 million comprised share buybacks, with the Company having acquired 562,025 ordinary shares under the EUR 15 million program announced in October 2025.

 

Finally, the Company has extended its share buyback program through to 30 April 2026, enabling utilisation of the remaining allocated amount. With approximately EUR 8.1 million in cumulative share buybacks as of the end of January, the Board remains focused on deploying the program proactively to create shareholder value.

 

Ends.

 

About Partners Group Private Equity Limited

PGPE Ltd is an investment holding company founded in 1999 and domiciled in Guernsey. It invests in private equity direct investments. PGPE Ltd is managed in its investment activities by Partners Group, one of the largest firms in the global private markets industry, with USD 185 billion in investment programs under management in private markets, of which USD 86 billion is in private equity. Partners Group itself is listed on the Swiss Stock Exchange (ticker: PGHN). PGPE Ltd aims to provide shareholders with long-term capital growth and an attractive dividend yield. PGPE Ltd is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro quote; PEYS for the Sterling quote).

 

 

Contacts

Partners Group Private Equity Limited:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

 

Investor relations contact:

Andreea Mateescu

Phone: +41 41 784 66 73

E-mail: andreea.mateescu@partnersgroup.com

 

Media relations contact:

Jenny Blinch

Phone: +41 41 784 65 26

E-mail: jenny.blinch@partnersgroup.com

 

Registered Number: 35241 LEI: 54930038LU8RDPFFVJ57

Notes:

1. Note that references in this announcement to Partners Group Private Equity Limited have been abbreviated to "PGPE Ltd" or "the Company". References to Partners Group AG have been abbreviated to "Partners Group" or "the Investment Manager".

2. This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Partners Group Private Equity Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

3. This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of PGPE Ltd's website nor the contents of any website accessible from hyperlinks on PGPE Ltd's website (or any other website) are incorporated into, or form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNONRNOUUARR
Date   Source Headline
27th May 20267:00 amRNSPGPE Ltd results presentation webcast details
18th May 20267:00 amRNSSave the date for Q1 2026 results announcement
7th May 20267:00 amRNSPGPE Ltd publishes March NAV
5th May 20267:00 amRNSDividend Declaration
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSNotice of Annual General Meeting
14th Apr 20267:00 amRNSPGPE Ltd publishes February NAV
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSBuyback update
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSAnnual results and webcast details
16th Mar 20267:00 amRNSPGPE Ltd publishes January NAV
16th Mar 20267:00 amRNSSave the date for 2025 annual results announcement
16th Mar 20267:00 amRNSSave the date for 2025 annual results announcement
16th Mar 20267:00 amRNSPGPE Ltd publishes January NAV
25th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSPGPE Ltd publishes December NAV
12th Feb 20264:51 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:01 amRNSBuyback update
28th Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSFree Cash Flow as at 31 December 2025
8th Jan 20267:04 amRNSPGPE Ltd publishes November NAV
24th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSNAV increased by 0.5% in October
10th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
27th Nov 20257:05 amRNSSale of Convex Group
27th Nov 20257:00 amRNSEsentia lists on Mexican Stock Exchange
26th Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSResults presentation webcast details
20th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSCredit facility renewed early
12th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSDividend Declaration
4th Nov 20257:00 amRNSNAV increased by 2.1% in September
4th Nov 20257:00 amRNSSave the date for Q3 2025 results announcement
3rd Nov 20257:00 amRNSSale of Clario
30th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.